Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

202 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
The combination of calcipotriol and methotrexate compared with methotrexate and vehicle in psoriasis: results of a multicentre placebo-controlled randomized trial.
de Jong EM, Mørk NJ, Seijger MM, De La Brassine M, Lauharanta J, Jansen CT, Guilhou JJ, Guillot B, Ostrojic A, Souteyrand P, Vaillant L, Barnes L, Rogers S, Klaber MR, Van De Kerkhof PC. de Jong EM, et al. Among authors: souteyrand p. Br J Dermatol. 2003 Feb;148(2):318-25. doi: 10.1046/j.1365-2133.2003.05173.x. Br J Dermatol. 2003. PMID: 12588386 Clinical Trial.
A novel therapeutic approach to psoriasis with combination calcipotriol ointment and very low-dose cyclosporine: results of a multicenter placebo-controlled study.
Grossman RM, Thivolet J, Claudy A, Souteyrand P, Guilhou JJ, Thomas P, Amblard P, Belaich S, de Belilovsky C, de la Brassinne M, et al. Grossman RM, et al. Among authors: souteyrand p. J Am Acad Dermatol. 1994 Jul;31(1):68-74. doi: 10.1016/s0190-9622(94)70138-5. J Am Acad Dermatol. 1994. PMID: 8021375 Clinical Trial.
Efficacy and safety of calcipotriol (MC 903) ointment in psoriasis vulgaris. A randomized, double-blind, right/left comparative, vehicle-controlled study.
Dubertret L, Wallach D, Souteyrand P, Perussel M, Kalis B, Meynadier J, Chevrant-Breton J, Beylot C, Bazex JA, Jurgensen HJ. Dubertret L, et al. Among authors: souteyrand p. J Am Acad Dermatol. 1992 Dec;27(6 Pt 1):983-8. doi: 10.1016/0190-9622(92)70299-u. J Am Acad Dermatol. 1992. PMID: 1479106 Clinical Trial.
Treatment of early-stage mycosis fungoides with twice-weekly applications of mechlorethamine and topical corticosteroids: a prospective study.
de Quatrebarbes J, Estève E, Bagot M, Bernard P, Beylot-Barry M, Delaunay M, D'Incan M, Souteyrand P, Vaillant L, Cordel N, Courville P, Joly P. de Quatrebarbes J, et al. Among authors: souteyrand p. Arch Dermatol. 2005 Sep;141(9):1117-20. doi: 10.1001/archderm.141.9.1117. Arch Dermatol. 2005. PMID: 16172308 Clinical Trial.
A prospective study of cutaneous intolerance to topical mechlorethamine therapy in patients with cutaneous T-cell lymphomas. French Study Group of Cutaneous Lymphomas.
Estève E, Bagot M, Joly P, Souteyrand P, Beylot-Barry M, Vaillant L, Delaunay M, Avril MF, Laroche L, Grange F, Thomine E, Wechsler J. Estève E, et al. Among authors: souteyrand p. Arch Dermatol. 1999 Nov;135(11):1349-53. doi: 10.1001/archderm.135.11.1349. Arch Dermatol. 1999. PMID: 10566833
Melanoma and tumor thickness: challenges of early diagnosis.
Richard MA, Grob JJ, Avril MF, Delaunay M, Thirion X, Wolkenstein P, Souteyrand P, Dreno B, Bonerandi JJ, Dalac S, Machet L, Guillaume JC, Chevrant-Breton J, Vilmer C, Aubin F, Guillot B, Beylot-Barry M, Lok C, Raison-Peyron N, Chemaly P. Richard MA, et al. Among authors: souteyrand p. Arch Dermatol. 1999 Mar;135(3):269-74. doi: 10.1001/archderm.135.3.269. Arch Dermatol. 1999. PMID: 10086447
202 results